204 related articles for article (PubMed ID: 22011358)
1. Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with Duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiovascular magnetic resonance.
Hor KN; Mazur W; Taylor MD; Al-Khalidi HR; Cripe LH; Jefferies JL; Raman SV; Chung ES; Kinnett KJ; Williams K; Gottliebson WM; Benson DW
J Cardiovasc Magn Reson; 2011 Oct; 13(1):60. PubMed ID: 22011358
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X-linked dilated cardiomyopathy.
Bourke JP; Bueser T; Quinlivan R
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009068. PubMed ID: 30326162
[TBL] [Abstract][Full Text] [Related]
3. Progressive left ventricular dysfunction and myocardial fibrosis in Duchenne and Becker muscular dystrophy: a longitudinal cardiovascular magnetic resonance study.
Aikawa T; Takeda A; Oyama-Manabe N; Naya M; Yamazawa H; Koyanagawa K; Ito YM; Anzai T
Pediatr Cardiol; 2019 Feb; 40(2):384-392. PubMed ID: 30564867
[TBL] [Abstract][Full Text] [Related]
4. Myocardial Fibrosis Progression in Duchenne and Becker Muscular Dystrophy: A Randomized Clinical Trial.
Silva MC; Magalhães TA; Meira ZM; Rassi CH; Andrade AC; Gutierrez PS; Azevedo CF; Gurgel-Giannetti J; Vainzof M; Zatz M; Kalil-Filho R; Rochitte CE
JAMA Cardiol; 2017 Feb; 2(2):190-199. PubMed ID: 27926769
[TBL] [Abstract][Full Text] [Related]
5. Non-contrast cardiovascular magnetic resonance detection of myocardial fibrosis in Duchenne muscular dystrophy.
Raucci FJ; Xu M; George-Durrett K; Crum K; Slaughter JC; Parra DA; Markham LW; Soslow JH
J Cardiovasc Magn Reson; 2021 Apr; 23(1):48. PubMed ID: 33910579
[TBL] [Abstract][Full Text] [Related]
6. Localized strain characterization of cardiomyopathy in Duchenne muscular dystrophy using novel 4D kinematic analysis of cine cardiovascular magnetic resonance.
Earl CC; Pyle VI; Clark SQ; Annamalai K; Torres PA; Quintero A; Damen FW; Hor KN; Markham LW; Soslow JH; Goergen CJ
J Cardiovasc Magn Reson; 2023 Feb; 25(1):14. PubMed ID: 36793101
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal changes in cardiac function in Duchenne muscular dystrophy population as measured by magnetic resonance imaging.
Batra A; Barnard AM; Lott DJ; Willcocks RJ; Forbes SC; Chakraborty S; Daniels MJ; Arbogast J; Triplett W; Henricson EK; Dayan JG; Schmalfuss C; Sweeney L; Byrne BJ; McDonald CM; Vandenborne K; Walter GA
BMC Cardiovasc Disord; 2022 Jun; 22(1):260. PubMed ID: 35681116
[TBL] [Abstract][Full Text] [Related]
8. Left ventricular T2 distribution in Duchenne muscular dystrophy.
Wansapura JP; Hor KN; Mazur W; Fleck R; Hagenbuch S; Benson DW; Gottliebson WM
J Cardiovasc Magn Reson; 2010 Mar; 12(1):14. PubMed ID: 20298602
[TBL] [Abstract][Full Text] [Related]
9. T
Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
[TBL] [Abstract][Full Text] [Related]
10. Effects of cardiac medications on ventricular function in patients with Duchenne muscular dystrophy-related cardiomyopathy.
Murphy AP; Johnson A; Straub V; Heads-Baister A; Lord S; Bourke JP
Muscle Nerve; 2021 Aug; 64(2):163-171. PubMed ID: 34050938
[TBL] [Abstract][Full Text] [Related]
11. Stabilization of Early Duchenne Cardiomyopathy With Aldosterone Inhibition: Results of the Multicenter AIDMD Trial.
Raman SV; Hor KN; Mazur W; Cardona A; He X; Halnon N; Markham L; Soslow JH; Puchalski MD; Auerbach SR; Truong U; Smart S; McCarthy B; Saeed IM; Statland JM; Kissel JT; Cripe LH
J Am Heart Assoc; 2019 Oct; 8(19):e013501. PubMed ID: 31549577
[TBL] [Abstract][Full Text] [Related]
12. Cardiac profile of asymptomatic children with Becker and Duchenne muscular dystrophy under treatment with steroids and with/without perindopril.
Mavrogeni S; Giannakopoulou A; Papavasiliou A; Markousis-Mavrogenis G; Pons R; Karanasios E; Noutsias M; Kolovou G; Papadopoulos G
BMC Cardiovasc Disord; 2017 Jul; 17(1):197. PubMed ID: 28738778
[TBL] [Abstract][Full Text] [Related]
13. Variations in native T1 values in patients with Duchenne muscular dystrophy with and without late gadolinium enhancement.
Lang SM; Alsaied T; Khoury PR; Ryan TD; Taylor MD
Int J Cardiovasc Imaging; 2021 Feb; 37(2):635-642. PubMed ID: 32951096
[TBL] [Abstract][Full Text] [Related]
14. Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.
Raman SV; Hor KN; Mazur W; Halnon NJ; Kissel JT; He X; Tran T; Smart S; McCarthy B; Taylor MD; Jefferies JL; Rafael-Fortney JA; Lowe J; Roble SL; Cripe LH
Lancet Neurol; 2015 Feb; 14(2):153-61. PubMed ID: 25554404
[TBL] [Abstract][Full Text] [Related]
15. Comparison of magnetic resonance feature tracking for strain calculation with harmonic phase imaging analysis.
Hor KN; Gottliebson WM; Carson C; Wash E; Cnota J; Fleck R; Wansapura J; Klimeczek P; Al-Khalidi HR; Chung ES; Benson DW; Mazur W
JACC Cardiovasc Imaging; 2010 Feb; 3(2):144-51. PubMed ID: 20159640
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin-converting enzyme inhibitors and/or beta blockers on the cardiomyopathy in Duchenne muscular dystrophy.
Viollet L; Thrush PT; Flanigan KM; Mendell JR; Allen HD
Am J Cardiol; 2012 Jul; 110(1):98-102. PubMed ID: 22463839
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.
Hor KN; Taylor MD; Al-Khalidi HR; Cripe LH; Raman SV; Jefferies JL; O'Donnell R; Benson DW; Mazur W
J Cardiovasc Magn Reson; 2013 Dec; 15(1):107. PubMed ID: 24359596
[TBL] [Abstract][Full Text] [Related]
18. Initial application of three-dimensional speckle-tracking echocardiography to detect subclinical left ventricular dysfunction and stratify cardiomyopathy associated with Duchenne muscular dystrophy in children.
Yu HK; Xia B; Liu X; Han C; Chen W; Li Z
Int J Cardiovasc Imaging; 2019 Jan; 35(1):67-76. PubMed ID: 30105418
[TBL] [Abstract][Full Text] [Related]
19. Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients.
Florian A; Ludwig A; Engelen M; Waltenberger J; Rösch S; Sechtem U; Yilmaz A
J Cardiovasc Magn Reson; 2014 Sep; 16(1):81. PubMed ID: 25315351
[TBL] [Abstract][Full Text] [Related]
20. Cardiac Involvement in Duchenne Muscular Dystrophy and Related Dystrophinopathies.
Mavrogeni SI; Markousis-Mavrogenis G; Papavasiliou A; Papadopoulos G; Kolovou G
Methods Mol Biol; 2018; 1687():31-42. PubMed ID: 29067654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
